Arterra Bioscience S.p.A. (BIT:ARBS)

Italy · Delayed Price · Currency is EUR

3.020

-0.080 (-2.58%)

Oct 16, 2026, 5:35 PM CET

Arterra Bioscience Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.2	4.7	4.17	3.34	3.59	4.74
Revenue Growth	7.89%	12.74%	25.08%	-7.10%	-24.27%	13.64%
Gross Profit	3.19	2.94	2.41	1.85	2.44	3.3
Operating Income	1.91	1.93	1.37	1.06	1.6	1.25
Net Income	1.66	2.01	1.34	1.08	1.41	1.11
Earnings Per Share	0.25	0.30	0.20	0.16	-	-
EPS Growth	-	50.09%	24.21%	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Italy	2.6
Abroad	2.05
Total	4.65

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.31	1.34	3.34	3.69	5.99	4.81
Total Debt	0.24	0.26	0.36	0.39	0.49	0.61
Net Cash (Debt)	1.07	1.08	2.99	3.3	5.5	4.2
Net Cash Growth	-65.82%	-63.77%	-9.48%	-40.03%	31.02%	12.69%
Net Cash Per Share	0.16	0.16	0.45	0.50	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1.67	1.99	1.06	1.03	1.4	1.4
Capital Expenditures	-0.47	-0.45	-0.64	-0.07	-0.09	-0.54
Free Cash Flow	1.2	1.54	0.42	0.96	1.3	0.86
Free Cash Flow Growth	8.20%	263.33%	-55.88%	-26.22%	51.99%	521.51%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	61.35%	62.44%	57.85%	55.46%	68.03%	69.69%
Operating Margin	36.72%	41.06%	32.90%	31.75%	44.57%	26.32%
Pretax Margin	37.97%	42.46%	40.77%	39.03%	50.05%	26.86%
Profit Margin	31.99%	42.64%	32.03%	32.26%	39.38%	23.42%
FCF Margin	23.13%	32.71%	10.15%	28.77%	36.23%	18.05%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.130	-	0.130	0.100	0.100	0.050
Dividend Per Share Growth	15.38%	-	30.00%	0%	100.00%	-
Dividend Yield	4.30%	-	6.63%	6.02%	5.66%	2.15%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.41	10.02	9.76	10.27	10.17	17.17
P/FCF Ratio	17.17	13.07	30.81	11.52	11.06	22.28
PS Ratio	3.97	4.27	3.13	3.31	4.01	4.02